My ASCO: Centre for Trials Research at the American Society of Clinical Oncology 2019
25 July 2019Background
This year I’ve had the great opportunity to attend ASCO (American Society of Clinical Oncology) conference as a Centre for Trials Research representative together with Professor Richard Adams, Director Cancer Division, and Catrin Cox for the presentation of the FAKTION study by the Chief Investigators (CIs), Dr Sacha Howell (University of Manchester and The Christie NHS Foundation Trust) and Dr Rob Jones (Velindre Cancer Centre and Cardiff University).
Before departure, Richard had explained: “It’s a huge conference. Don’t get scared!”. Which was translated in my head: “Don’t get lost! And play the Centre for Trials Research representative role!”.
Scale of ASCO
A conference attended by 40,000 people from all over the world and taking place in a 2.6 million square feet convention centre can be described as huge…or normal for the American standard. The convention centre was divided into 4 wings: it took me at least 10 minutes to walk from one wing to another. This forced activity of stretching my legs while moving from one session to the other has challenged my idea of conference paralysis gain from my long-term experience of attending conferences, where the only stretching activity is to lift a cup of tea/coffee while going back home with a painful stiff neck for looking at slides from the never-good seat.
Highlights
The presentation on how consultants should talk to their patients about their cancer and how to offer them the opportunity to enter a trial: what words to use and what to avoid, what attitude to have, and what understanding of the other’s pain should underline every word. This presentation made me think of our Participant Information Sheets. We write all the sections that our Centre for Trials Research Standard Operating Procedure (SOP) recommends and we ask our Patient and Public Involvement (PPI) representatives to review it, because this is what our potential funder and Research Ethics Committee (REC) need to see evidenced. But, once it is out with our sites, it is the Principal Investigator (PI) and Research Nurse who explain the Participant Information Sheet (PIS) to the patient as the potential participant of our cancer trials. The clearest, simplest word we may have written has to be translated by professionals with the use of one dictionary: compassion. Do our PIS facilitate their communication with cancer patients? Do we use the same dictionary?
The Women’s Networking Center offered some inspiring talks by women for women in an atmosphere of mutual recognition and complicity. A refreshing break from the lone wolf academic presenter competing with colleagues for a moment of high visibility and glory.
Regulations and costs
Finally, a session on the financial aspects of the trials. Though the talks were based on laws and regulations in US, the case of an American woman who travelled to Europe at her own expense for entering a trial and getting access to a drug not available in her country reinforced my idea that, in the era of globalisation, trials need to be more inclusive and national-boundary free in opposition to the political agenda of some countries.
If there is one thing I’ve brought back from this conference is a feeling of urgency. As a fully-registered Clinical Trials Unit (CTU), our role is to facilitate the running of clinical trials, to streamline the often unnecessarily burdensome process, and to support the research ideas of our consultants.
FAKTION presentation
I attended the session with the FAKTION presentation by our CI, Dr Sacha Howell. I think that was the main reason why I went there. It took place in the largest hall of the venue ….and it was fully packed. Our CI was superb: calm, clear, concise during the presentation and in answering the audience’s questions. FAKTION is not an easy trial to manage but at the end it is worthy – not just for the results and hope we can give to many women suffering from breast cancer – but for what is behind the scene: an excellent and inspiring teamwork.
We’re now working on the publication. Watch this space.
To find out more about FAKTION please go to https://www.cardiff.ac.uk/centre-for-trials-research/research/studies-and-trials/view/faktion
- November 2024
- October 2024
- September 2024
- July 2024
- June 2024
- May 2024
- April 2024
- March 2024
- December 2023
- November 2023
- September 2023
- July 2023
- June 2023
- April 2023
- March 2023
- February 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- November 2021
- September 2021
- July 2021
- June 2021
- May 2021
- March 2021
- February 2021
- December 2020
- November 2020
- September 2020
- August 2020
- July 2020
- January 2020
- December 2019
- October 2019
- September 2019
- July 2019
- June 2019
- May 2019
- April 2019
- February 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- December 2017
- October 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- October 2016
- August 2016
- June 2016
- April 2016
- March 2016
- February 2016